Isogenica Nature Webinar: ‘VHH as building blocks for immune and tumour cell-targeting’
Join us for our upcoming webinar with Nature Research Custom Media on ‘VHH as building blocks for immune and tumour cell-targeting’, presented by our CSO Bill Eldridge. This presentation will expand on the recent advances in the field of VHH-based therapeutics and highlight particular therapy applications where a naturally monovalent antibody domain structure can be combined to generate the next generation of biologics. Register for the webinar now to learn all about the incredible potential and latest developments of VHH in next generation therapeutics. Register here
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.